[Epileptic spasms in infants. Beyond hypsarrhythmia]

M Garcia-Fernandez1

  • 1Hospital Infantil Universitario Nino Jesus, 28009 Madrid, Espana.

Insights

Epileptic spasms, common in infants, present varied clinical signs and EEG patterns. EEG-video studies with electromyography aid in accurate diagnosis and management of these seizures.

Area of Science:

  • Neurology
  • Pediatric Neurology
  • Epileptology

Background:

  • Epileptic spasms are the most common seizure type in infants, but can occur in other contexts.
  • Clinical presentation and EEG correlates of epileptic spasms are highly variable.
  • Distinguishing epileptic spasms from other paroxysmal events is crucial for diagnosis and treatment.

Purpose of the Study:

  • To highlight the diagnostic challenges of epileptic spasms.
  • To emphasize the utility of EEG-video studies, including electromyography, in diagnosing subtle spasms.
  • To underscore the importance of accurate diagnosis for optimizing therapeutic and etiological management.

Main Methods:

  • Review of clinical semiology and EEG findings in epileptic spasms.
  • Utilization of EEG-video studies with electromyographic recording of deltoids.
  • Differential diagnosis of paroxysmal episodes that may be mistaken for epileptic spasms.

Main Results:

  • Epileptic spasms exhibit diverse clinical manifestations, sometimes lacking typical features.
  • EEG correlates are variable, not always including classic hypsarrhythmia.
  • Electromyography aids in detecting subtle spasms and defining their characteristics.
  • EEG-video studies are pivotal for differential diagnosis.

Conclusions:

  • EEG-video studies are essential for accurate diagnosis and classification of epileptic spasms and related syndromes.
  • Improved diagnosis through EEG-video analysis can optimize treatment strategies and etiological investigations.
  • Recognizing the variability in presentation is key to avoiding misdiagnosis.

Related Concept Videos

Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
1.9K
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.5K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.0K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.0K
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.5K
Antiepileptic Drugs: Calcium Channel Blockers01:17

Antiepileptic Drugs: Calcium Channel Blockers

Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
1.5K